Respiratory hospitalizations and respiratory syncytial virus prophylaxis in special populations

Palivizumab utilization, compliance, and outcomes were examined in infants with preexisting medical diseases within the Canadian Registry Database (CARESS) to aid in developing guidelines for potential “at-risk” infants in the future. Infants who received ≥1 dose of palivizumab during the 2006–2010...

Descripción completa

Detalles Bibliográficos
Autores principales: Paes, B., Mitchell, I., Li, A., Lanctôt, K.L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3327836/
https://www.ncbi.nlm.nih.gov/pubmed/22203430
http://dx.doi.org/10.1007/s00431-011-1654-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3327836/
https://www.ncbi.nlm.nih.gov/pubmed/22203430
http://dx.doi.org/10.1007/s00431-011-1654-8

Ejemplares similares